UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | I | K | L | M | N | O | P | R | S | V | W | Z
Number of items: 141.

A

Ahmed, M; Miller, A; Hanna, MG; Greensmith, L; (2011) Investigating the effects of pharmacological up-regulation of the heat shock response on protein degradation pathways in an in-vitro model of sporadic inclusion body myositis. In: NEUROMUSCULAR DISORDERS. (pp. S26 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Ahmed, Z; Asi, YT; Lees, AJ; Revesz, T; Holton, JL; (2011) Investigating the role of oligodendroglial precursor cells in multiple system atrophy and progressive supranuclear palsy. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 21 - 21). WILEY-BLACKWELL PUBLISHING, INC

Alarcón, F; Dueñas, G; Lees, A; (2011) Encephalitis lethargica due to Epstein-Barr virus infection. Mov Disord , 26 (11) pp. 2132-2134. 10.1002/mds.23772.

Allen, G.F.G.; (2011) The neurochemical consequences of aromatic L-amino acid decarboxylase deficiency. Doctoral thesis , UCL (University College London). Green open access
file

Anzak, A; Tan, H; Pogosyan, A; Ling, H; Lees, AJ; Brown, P; (2011) Improvements in rate of development and magnitude of force with intense auditory stimuli in patients with Parkinson's disease. European Journal of Neuroscience , 34 (1) pp. 124-132.

B

Balazs, R; Vernon, J; Hardy, J; (2011) Epigenetic mechanisms in Alzheimer's disease: progress but much to do. NEUROBIOL AGING , 32 (7) 1181 - 1187. 10.1016/j.neurobiolaging.2011.02.024.

Bandopadhyay, R; Mamais, A; Lashley, T; Griffiths, C; Goswami, N; Holton, JL; Revesz, T; (2011) The role of 4E-BP1, a putative LRRK2 interactor in the pathology of IPD and in G2019S LRRK2 mutation cases. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 21 - 21). WILEY-BLACKWELL PUBLISHING, INC

Brady, S; Squier, W; Hanna, MG; Hilton-Jones, D; Sewry, C; Holton, JL; (2011) Inclusion body myositis: a diagnostic challenge. In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Brady, S; Squier, W; Hilton-Jones, D; Sewry, C; Holton, JL; (2011) Inclusion body myositis: A diagnostic challenge. In: (Proceedings) 16th International Congress of the World-Muscle-Society. (pp. pp. 732-733). PERGAMON-ELSEVIER SCIENCE LTD

Brys, M; Glodzik, L; Mosconi, L; Switalski, R; De Santi, S; Pirraglia, E; Rich, K; ... De Leon, MJ; + view all (2011) Quantitative structural MRI and CSF biomarkers in early diagnosis of Alzheimer's disease. Advances in Alzheimer's Disease , 2 pp. 141-152. 10.3233/978-1-60750-793-2-141.

Burge, J; Hanna, MG; (2011) Muscle Channelopathies. pp. 96-102. 10.1002/9781119973331.ch13.

Burge, J; Horga, A; Griggs, RC; Hanna, MG; HYP HOP Investigators, ; (2011) Double-blind, placebo-controlled, parallel group, phase Ill study comparing dichlorphenamide vs. placebo for the treatment of periodic paralysis (HYP HOP trial). In: NEUROMUSCULAR DISORDERS. (pp. S13 - S13). PERGAMON-ELSEVIER SCIENCE LTD

C

Carlozzi, NE; Stout, JC; Mills, JA; Duff, K; Beglinger, LJ; Aylward, EH; Whitlock, KB; ... Paulsen, JS; + view all (2011) Estimating Premorbid IQ in the Prodromal Phase of a Neurodegenerative Disease. CLINICAL NEUROPSYCHOLOGIST , 25 (5) pp. 757-777. 10.1080/13854046.2011.577811.

Casper, CJ; Warner, TT; Taanman, JW; Nathwani, AC; (2011) Generation of iPS-derived dopaminergic neurons as an in-vitro model of Rapid-Onset Dystonia Parkinsonism. HUMAN GENE THERAPY , 22 (10) A42 - A43.

Constantinescu, R; Holmberg, B; Rosengren, L; Corneliusson, O; Johnels, B; Zetterberg, H; (2011) Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson's disease. ACTA NEUROLOGICA SCANDINAVICA , 124 (3) pp. 206-210. 10.1111/j.1600-0404.2010.01451.x.

Coop, M; (2011) Untitled. GEOTECHNIQUE LETTERS , 1 p. 1. 10.1680/geolett.11.00013.

Crehan, H; Pocock, JM; Hardy, J; (2011) THE ROLE OF MICROGLIAL COMPLEMENT RECEPTOR 1 (CR1) IN ALZHEIMER'S DISEASE. In: GLIA. (pp. S135 - S135). WILEY-BLACKWELL

D

Dahlgren, A; Wargelius, H-L; Berglund, KJ; Fahlke, C; Blennow, K; Zetterberg, H; Oreland, L; ... Balldin, J; + view all (2011) Do Alcohol-dependent Individuals with DRD2 A1 Allele Have an Increased Risk of Relapse? A Pilot Study. ALCOHOL AND ALCOHOLISM , 46 (5) pp. 509-513. 10.1093/alcalc/agr045.

Deriziotis, P; Andre, R; Smith, DM; Goold, R; Kinghorn, KJ; Kristiansen, M; Nathan, JA; ... Tabrizi, SJ; + view all (2011) Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. EMBO J , 30 (15) 3065 - 3077. 10.1038/emboj.2011.224.

Djamshidian, A; Cardoso, F; Grosset, D; Bowden-Jones, H; Lees, AJ; (2011) Pathological Gambling in Parkinson's Disease-A Review of the Literature. MOVEMENT DISORD , 26 (11) 1976 - 1984. 10.1002/mds.23821.

Djamshidian, A; O apos Sullivan, SS; Doherty, K; Lees, AJ; Averbeck, BB; (2011) Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour. Neuropsychologia , 49 (1) pp. 103-107. 10.1016/j.neuropsychologia.2010.10.012.

Djamshidian, A; O'Sullivan, SS; Wittmann, BC; Lees, AJ; Averbeck, BB; (2011) Novelty seeking behaviour in Parkinson's disease. Neuropsychologia

Djamshidian, A; O'sullivan, SS; Papadopoulos, A; Bassett, P; Shaw, K; Averbeck, BB; Lees, AJ; (2011) Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour. In: (Proceedings) 15th International Congress of Parkinsons Disease and Movement Disorders. (pp. S101-S101). WILEY-BLACKWELL

Duchen, MR; Heath, K; Baruch, NB; Hanna, MG; Muntoni, F; (2011) Dysregulation of calcium and mitochondrial function as potential therapeutic targets in muscle disease. In: NEUROMUSCULAR DISORDERS. (pp. S1 - S2). PERGAMON-ELSEVIER SCIENCE LTD

Dunn, L.M.; (2011) Characterisation of leucine-rich repeat kinase-2 regulation and kinase function. Doctoral thesis , UCL (University College London). Green open access
file

Durran, S; Matthews, E; Rayan, DLR; Sud, R; Polke, J; Haworth, A; Holton, JL; ... Hanna, MG; + view all (2011) Genetic heterogeneity and mechanisms of phenotypic variability in human skeletal muscle channelopathies - a new S4 mutation not associated with HypoPP. In: NEUROMUSCULAR DISORDERS. (pp. S13 - S13). PERGAMON-ELSEVIER SCIENCE LTD

F

Fabbrini, G; Merello, M; Evans, AH; Lees, AJ; Holton, J; Williams, DR; (2011) Progressive Parkinsonism, Oculomotor Abnormalities and Autonomic Dysfunction: Clinicopathological Case. MOVEMENT DISORD , 26 (3) 424 - 429. 10.1002/mds.23302.

Fabbrini, G; Merello, M; Evans, AH; Lees, AJ; Holton, J; Williams, DR; (2011) Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: Clinicopathological case. Movement Disorders , 26 (3) pp. 424-429. 10.1002/mds.23302.

Fawcett, K; Murphy, SM; Polke, J; Reilly, MM; Houlden, H; (2011) TRPV4 mutations and functional characterisation in a cohort of patients with hereditary neuropathy. In: NEUROMUSCULAR DISORDERS. (pp. S16 - S16). PERGAMON-ELSEVIER SCIENCE LTD

Fawcett, K; Murphy, SM; Reilly, MM; Houlden, H; (2011) TRPV4 MUTATIONS AND FUNCTIONAL CHARACTERISATION IN A COHORT OF PATIENTS WITH HEREDITARY NEUROPATHY. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S36 - S36). WILEY-BLACKWELL

Fletcher, E.V.; (2011) Alternative splicing in SCN1A: biophysical consequences for NaV1.1 channels. Doctoral thesis , UCL (University College London). Green open access
file

G

Gray, A; Malik, B; Montague, K; Dick, J; Hanna, MG; Greensmith, L; (2011) Investigating pathophysiology and therapeutic strategies in a mouse model of spinal and bulbar muscular atrophy (SBMA). In: NEUROMUSCULAR DISORDERS. (pp. S10 - S10). PERGAMON-ELSEVIER SCIENCE LTD

H

Hardy, J; (2011) Read all about it! NEW SCI , 211 (2822) 22 - 23.

Hardy, J; Low, NC; (2011) Genes and Environment in Psychiatry Winner's Curse or Cure? ARCH GEN PSYCHIAT , 68 (5) 455 - 456.

Haworth, A; Bertram, L; Carrera, P; Elson, JL; Braastad, CD; Cox, DW; Cruts, M; ... Sobrido, MJ; + view all (2011) Call for participation in the neurogenetics consortium within the Human Variome Project. NEUROGENETICS , 12 (3) 169 - 173. 10.1007/s10048-011-0287-4.

Holmstrom, KM; Gourine, AV; Abramov, AY; (2011) A Novel Role for Polyphosphate in Astrocyte Signalling. In: (Proceedings) 55th Annual Meeting of the Biophysical-Society. (pp. p. 562). CELL PRESS

Holton, JL; Lees, AJ; Revesz, T; (2011) Multiple System Atrophy. pp. 242-252. 10.1002/9781444341256.ch24.

I

Innes, A; Kalmar, B; Houlden, H; Reilly, MM; Greensmith, L; (2011) Characterisation of novel mutations within heat shock protein 27 causing motor axonopathies. In: NEUROMUSCULAR DISORDERS. (pp. S3 - S3). PERGAMON-ELSEVIER SCIENCE LTD

K

Kalmar, B; Innes, A; Rossor, AM; Houlden, H; Schiavo, G; Reilly, MM; Greensmith, L; (2011) ASSESSMENT OF FUNCTIONAL IMPAIRMENTS IN CELLULAR MODELS OF MUTANT HSPB1 INDUCED NEUROPATHIES. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S62 - S63). WILEY-BLACKWELL

Koepke, J; Haag, C; Feldbrügge, M; Kaffarnik, F; Zarnack, K; Luscombe, NM; König, J; ... Begerow, D; + view all (2011) The RNA-binding protein Rrm4 is essential for efficient secretion of endochitinase Cts1. Molecular and Cellular Proteomics , 10 (12) 10.1074/mcp.M111.011213.

Kojovic, M; Sheerin, UM; Wood, N; Houlden, H; Hardy, J; Bhatia, KP; (2011) Young onset parkinsonism due to alpha synuclein gene multiplication in a consanguineous family - A case report. In: (Proceedings) 15th International Congress of Parkinsons Disease and Movement Disorders. (pp. S310-S311). WILEY-BLACKWELL

Konig, J; Zarnack, K; Rot, G; Curk, T; Kayikci, M; Zupan, B; Turner, DJ; ... Ule, J; + view all (2011) iCLIP--transcriptome-wide mapping of protein-RNA interactions with individual nucleotide resolution. Journal of visualized experiments : JoVE (50)

Kovac, S; Domijan, A; Walker, MC; Abramov, AY; (2011) PROLONGED SEIZURE ACTIVITY IMPAIRS MITOCHONDRIAL BIOENERGETICS AND INDUCES CELL DEATH. In: (Proceedings) 3rd London-Innsbruck Colloquium on Status Epilepticus. (pp. p. 85). WILEY-BLACKWELL

Kovac, S; Domijan, A-M; Walker, MC; Abramov, AY; (2011) ROLE OF MITOCHONDRIAL FUNCTION IN SEIZURE-INDUCED NEURONAL CELL DEATH. In: (Proceedings) 29th International Epilepsy Congress. (pp. p. 45). WILEY-BLACKWELL

Kuo, LT; Tsai, SY; Groves, MJ; An, SF; Scaravilli, F; (2011) Gene Expression Profile in Rat Dorsal Root Ganglion Following Sciatic Nerve Injury and Systemic Neurotrophin-3 Administration. J MOL NEUROSCI , 43 (3) 503 - 515. 10.1007/s12031-010-9473-3.

L

Lashley, T; Holton, JL; Revesz, T; (2011) TDP-43 pathology may occur in the BRI2 gene-related dementias. ACTA NEUROPATHOL , 121 (4) 559 - 560. 10.1007/s00401-011-0811-5.

Laura, M; Eichler, FS; Hornemann, T; Polke, J; Davis, M; Bull, K; Houlden, H; (2011) HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1: CORRELATION OF SEVERITY AND PLASMA ATYPICAL DEOXY-SPHYNGOID BASES. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S72 - S73). WILEY-BLACKWELL

Lees, A; (2011) The Hurricane Port. [Book]. Mainstream Digital

Lees, AJ; (2011) CAN THERAPY MODIFY NATURAL EVOLUTION OF PARKINSON'S DISEASE? - CONTRA. In: (pp. p. 17).

Lees, AJ; (2011) THE NOSOLOGY OF PARKINSON'S DISEASE. In: (pp. p. 638).

Lindgren, HS; Rylander, D; Iderberg, H; Andersson, M; O'Sullivan, SS; Williams, DR; Lees, AJ; (2011) Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with Dyskinesia. Journal of Parkinson's Disease , 1 (4) pp. 347-357. 10.3233/JPD-2011-11068.

Ling, H; Bhidayasiri, R; (2011) Reduced Serum Caeruloplasmin Levels in Non-Wilsonian Movement Disorders. EUROPEAN NEUROLOGY , 66 (3) pp. 123-127. 10.1159/000330538.

Ling, H; Braschinsky, M; Taba, P; Luus, SM; Doherty, K; Hotter, A; Poewe, W; (2011) Decades of Delayed Diagnosis in 4 Levodopa-Responsive Young-Onset Monogenetic Parkinsonism Patients. MOVEMENT DISORD , 26 (7) 1337 - 1340. 10.1002/mds.23563.

Ling, H; Braschinsky, M; Taba, P; Lüüs, S-M; Doherty, K; Hotter, A; Poewe, W; (2011) Decades of delayed diagnosis in 4 levodopa-responsive young-onset monogenetic parkinsonism patients. Movement Disorders

Ling, H; Braschinsky, M; Taba, P; Lüüs, SM; Doherty, K; Hotter, A; Poewe, W; (2011) Decades of delayed diagnosis in 4 levodopa-responsive young-onset monogenetic parkinsonism patients. Movement Disorders , 26 (7) pp. 1337-1340. 10.1002/mds.23563.

Ling, H; Massey, L; Lunn, M; Lees, A; (2011) A rare cause of L-Dopa responsive parkinsonism: The answer lies in the eyes. In: (pp. S341-S341).

Ling, H; Polke, JM; Sweeney, MG; Haworth, A; Sandford, CA; Heales, SJ; Wood, NW; ... Lees, AJ; + view all (2011) An intragenic duplication in guanosine triphosphate cyclohydrolase-1 gene in a dopa-responsive dystonia family. Movement Disorders , 26 (5) pp. 905-909.

Liu, YT; Murphy, SM; Houlden, H; Reilly, MM; (2011) Neurofilament light chain polypeptide gene (NEFL) mutations in autosomal dominant or sporadic Charcot-Marie-Tooth disease. In: NEUROMUSCULAR DISORDERS. (pp. S17 - S17). PERGAMON-ELSEVIER SCIENCE LTD

Loublier, S; Bayot, A; Rak, M; El-Khoury, R; Bénit, P; Rustin, P; (2011) The NDUFB6 subunit of the mitochondrial respiratory chain complex I is required for electron transfer activity: a proof of principle study on stable and controlled RNA interference in human cell lines. Biochem Biophys Res Commun , 414 (2) pp. 367-372. 10.1016/j.bbrc.2011.09.078.

Ludtmann, MHR; Boeckeler, K; Williams, RSB; (2011) Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder. Semin Cell Dev Biol , 22 (1) pp. 105-113. 10.1016/j.semcdb.2010.11.002.

Léveillé, N; Elkon, R; Davalos, V; Manoharan, V; Hollingworth, D; Oude Vrielink, J; le Sage, C; ... Agami, R; + view all (2011) Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nature Communications , 2 , Article 513. 10.1038/ncomms1519. Green open access
file

Léveillé, N; Elkon, R; Davalos, V; Vrielink, JO; Le Sage, C; Melo, CA; Esteller, M; ... Ule, J; + view all (2011) Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nature Communications , 2 (1) 10.1038/ncomms1519.

M

Machado, P; Miller, A; Parton, M; Dewar, L; Holton, JL; Dimachkie, M; Herbelir, L; ... Hanna, MG; + view all (2011) A randomised, double-blinded, placebo-controlled pilot study assessing the safety and tolerability of Arimoclomol in sporadic inclusion body myositis (IBM). In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Maennikkoe, R; Flanagan, SE; Sim, X; Segal, D; Hussain, K; Ellard, S; Hattersley, AT; (2011) Mutations of the Same Conserved Glutamate Residue in NBD2 of the Sulfonylurea Receptor 1 Subunit of the K-ATP Channel Can Result in Either Hyperinsulinism or Neonatal Diabetes. DIABETES , 60 (6) pp. 1813-1822. 10.2337/db10-1583.

Marelli, C; van de Leemput, J; Johnson, JO; Tison, F; Thauvin-Robinet, C; Picard, F; Tranchant, C; ... Brice, A; + view all (2011) SCA15 Due to Large ITPR1 Deletions in a Cohort of 333 White Families With Dominant Ataxia. ARCH NEUROL-CHICAGO , 68 (5) 637 - 643.

Matthews, E; Manzur, AY; Sud, R; Muntoni, F; Hanna, MG; (2011) Stridor as a Neonatal Presentation of Skeletal Muscle Sodium Channelopathy. ARCH NEUROL-CHICAGO , 68 (1) 127 - 129.

Matthews, E; Miller, JAL; Macleod, MR; Ironside, J; Ambler, G; Labrum, R; Sud, R; ... Hanna, MG; + view all (2011) SODIUM AND CHLORIDE CHANNELOPATHIES WITH MYOSITIS: COINCIDENCE OR CONNECTION? MUSCLE NERVE , 44 (2) 283 - 288. 10.1002/mus.22120.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) Found in translation: a blood-based test for Niemann-Pick type C1. Biomark Med , 5 (2) 201-. 10.2217/bmm.11.10.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) Growth factors in Parkinson's disease. Biomark Med , 5 (2) pp. 201-202.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) It is all about clearance. Biomark Med , 5 (2) 202-.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) Troponin T: more than acute myocardial infarction. Biomark Med , 5 (2) 203-.

Mattsson, N; Olsson, B; Andreasson, U; Portelius, E; Zetterberg, H; (2011) A new member in the biomarker discovery toolbox. Biomark Med , 5 (2) 202-.

Meschia, JF; Nalls, MA; Rich, SS; Singleton, A; Hardy, JA; Brott, TG; Brown, RD; ... SWISS Investigators, ; + view all (2011) Genome-wide Search for Ischemic Stroke Genes: The Siblings with Ischemic Stroke Study (SWISS). In: STROKE. (pp. E269 - E269). LIPPINCOTT WILLIAMS & WILKINS

Miller, A; Ahmed, M; Hanna, MG; Greensmith, L; (2011) The effects of arimoclomol on pathological outcome measures of inclusion body myositis in vitro. In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Miller, A; Machado, P; Morrow, JM; Hiscock, A; Dewar, L; Brady, S; Hilton-Jones, D; ... Parton, M; + view all (2011) The natural history of sporadic inclusion body myositis: development of an electronic database IBMnet. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S29). PERGAMON-ELSEVIER SCIENCE LTD

Morrow, JM; Dewar, EL; Ramdharry, GM; Laura, M; Yousry, TA; Hanna, MG; Reilly, MM; (2011) ISOMETRIC AND ISOKINETIC LOWER LIMB STRENGTH IN CHARCOT-MARIE-TOOTH DISEASE 1A. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S90 - S90). WILEY-BLACKWELL

Morrow, JM; Matthews, E; Rayan, DLR; Amer, I; Fischmann, A; Sinclair, CDJ; Thornton, JS; ... Hanna, MG; + view all (2011) Magnetic resonance imaging in the non-dystrophic myotonias. In: NEUROMUSCULAR DISORDERS. (pp. S5 - S5). PERGAMON-ELSEVIER SCIENCE LTD

Morrow, JM; Sinclair, CDJ; Fischmann, A; Thornton, JS; Laura, M; Yousry, TA; Hanna, MG; (2011) QUANTITATIVE MAGNETIC RESONANCE IMAGING OF MUSCLE IN CHARCOT-MARIE-TOOTH DISEASE 1A-A POTENTIAL OUTCOME MEASURE. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S90 - S90). WILEY-BLACKWELL

Mortberg, E; Zetterberg, H; Nordmark, J; Blennow, K; Catry, C; Decraemer, H; Vanmechelen, E; (2011) Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia. ACTA ANAESTHESIOLOGICA SCANDINAVICA , 55 (9) pp. 1132-1138. 10.1111/j.1399-6576.2011.02505.x.

Muller, T; Cirak, S; Parton, M; Lunn, M; Hanna, MG; Muntoni, F; (2011) An integrative database for clinical and research studies in neuromuscular diseases. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S29). PERGAMON-ELSEVIER SCIENCE LTD

Mulugeta, E; Londos, E; Hansson, O; Ballard, C; Skogseth, R; Minthon, L; Blennow, K; ... Aarsland, D; + view all (2011) Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates. Int J Alzheimers Dis , 2011 495025-. 10.4061/2011/495025.

Murphy, S; Laura, M; Blake, J; Polke, J; Bremner, F; Reilly, MM; (2011) Conduction block and tonic pupils in Charcot-Marie-Tooth disease caused by a Myelin Protein Zero p.Ile112Thr mutation. Neuromouscular Disorders , 21 pp. 223-226.

Murphy, S; Polke, J; Manji, H; Blake, J; Sweeney, M; Brandner, S; Reilly, MM; (2011) A novel mutation in the nerve-specific 5′UTR of the GJB1 gene causes X-linked Charcot-Marie-Tooth Disease. Journal of the Peripheral Nervous System , 16 pp. 65-70.

Murphy, S; Reilly, MM; (2011) Amyloid neuropathies. Advances in Clinical Neuroscience and Rehabilitation , 11 (1) pp. 16-19.

Murphy, SM; Siskind, C; Ovens, R; Polke, J; Laura, M; Houlden, H; Murphy, RPJ; ... Reilly, MM; + view all (2011) X-inactivation pattern in females with CMTX1. In: NEUROMUSCULAR DISORDERS. (pp. S18 - S18). PERGAMON-ELSEVIER SCIENCE LTD

Murphy, SM; Siskind, CE; Ovens, R; Polke, J; Laura, M; Houlden, H; Murphy, RPJ; ... Reilly, MM; + view all (2011) X-INACTIVATION PATTERN IN FEMALES WITH CMTX1. In: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. (pp. S94 - S94). WILEY-BLACKWELL

Mustafiz, T; Portelius, E; Gustavsson, MK; Holtta, M; Zetterberg, H; Blennow, K; Nordberg, A; (2011) Characterization of the Brain beta-Amyloid Isoform Pattern at Different Ages of Tg2576 Mice. NEURODEGENERATIVE DISEASES , 8 (5) pp. 352-363. 10.1159/000323871.

N

Nesbitt, V; Pitceathly, RDS; Rahman, S; Hanna, MG; McFarland, R; Turnbull, DM; (2011) A3243G-more than just MELAS! In: NEUROMUSCULAR DISORDERS. (pp. S21 - S21). PERGAMON-ELSEVIER SCIENCE LTD

Nesbitt, V; Pitceathly, RDS; Rahman, S; Poulton, J; Turnbull, DM; Hanna, MG; McFarland, R; (2011) The MRC Centre for Translational Research in Neuromuscular Disease: Mitochondrial Disease Patient Cohort Study UK. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S30). PERGAMON-ELSEVIER SCIENCE LTD

Nethisinghe, S; Clayton, L; Vermeer, S; Chapple, JP; Reilly, M; Bremner, F; Giunti, P; (2011) Retinal Imaging in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay. NEURO-OPHTHALMOLOGY , 35 (4) 197 - 201. 10.3109/01658107.2011.595043.

Noyce, AJ; Gilpin, P; Howard, R; Lees, AJ; Silviera-Moriyama, L; (2011) Severe dysphagia preceding Parkinson's disease. In: (Proceedings) 15th International Congress of Parkinsons Disease and Movement Disorders. (pp. S195-S196). WILEY-BLACKWELL

Nunes, A; Pressey, SNR; Cooper, JD; Soriano, S; (2011) Loss of amyloid precursor protein in a mouse model of Niemann-Pick type C disease exacerbates its phenotype and disrupts tau homeostasis. NEUROBIOL DIS , 42 (3) 349 - 359. 10.1016/j.nbd.2011.01.028.

O

O'Sullivan, SS; Johnson, M; Williams, DR; Revesz, T; Holton, JL; Lees, AJ; Perry, EK; (2011) The effect of drug treatment on neurogenesis in Parkinson's disease. Movement Disorders , 26 (1) pp. 45-50. 10.1002/mds.23340.

O'Sullivan, SS; Johnson, M; Williams, DR; Revesz, T; Holton, JL; Lees, AJ; Perry, EK; (2011) The effect of drug treatment on neurogenesis in Parkinson's disease. Mov Disord , 26 (1) pp. 45-50. 10.1002/mds.23340.

O'Sullivan, SS; Lees, AJ; (2011) Dopamine Dysregulation Syndrome. pp. 202-214. 10.1002/9781444397970.ch19.

P

Pandraud, A; Murphy, SM; Laura, M; Reilly, MM; Houlden, H; (2011) Genetic modifying factors for the common form of CMT1A due to the chromosome 17 duplication and other causes of CMT1 in non-CMT1A patients. In: NEUROMUSCULAR DISORDERS. (pp. S18 - S18). PERGAMON-ELSEVIER SCIENCE LTD

Parnetti, L; Chiasserini, D; Andreasson, U; Ohlson, M; Huls, C; Zetterberg, H; Minthon, L; ... Blennow, K; + view all (2011) Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. ACTA NEUROLOGICA SCANDINAVICA , 124 (2) pp. 122-129. 10.1111/j.1600-0404.2010.01435.x.

Peuralinna, T; Tanskanen, M; Makela, M; Polvikoski, T; Paetau, A; Kalimo, H; Sulkava, R; ... Myllykangas, L; + view all (2011) APOE and A beta PP Gene Variation in Cortical and Cerebrovascular Amyloid-beta Pathology and Alzheimer's Disease: A Population-Based Analysis. J ALZHEIMERS DIS , 26 (2) 377 - 385. 10.3233/JAD-2011-102049.

Phukan, J; Warner, TT; (2011) Other Dystonias. In: Oxford Textbook of Movement Disorders. Oxford University Press

Pitceathly, RDS; Fassone, E; Taanman, JW; Sadowski, M; Fratter, C; Mudanohwo, EE; Woodward, CE; ... Rahman, S; + view all (2011) Kearns-Sayre syndrome caused by defective R1/p53R2 assembly. NEUROMUSCULAR DISORDERS , 21 S21 - S21.

Pitceathly, RDS; Fassone, E; Taanman, JW; Sadowski, M; Fratter, C; Mudanohwo, EE; Woodward, CE; ... Rahman, S; + view all (2011) Kearns-Sayre syndrome caused by defective R1/p53R2 assembly. J MED GENET , 48 (9) 610 - 617. 10.1136/jmg.2010.088328.

Pitceathly, RDS; He, J; Foley, AR; Muntoni, F; Pearson, N; Hanna, MG; (2011) Whole genome analysis in a family with dominant muscle disease. In: NEUROMUSCULAR DISORDERS. (pp. S25 - S25). PERGAMON-ELSEVIER SCIENCE LTD

Pocock, J; Davenport, C; Jebelli, J; Sevastou, I; Hooper, C; (2011) P53-ACTIVATED PATHWAYS IN MICROGLIA: GOOD OR BAD FOR THE BRAIN? In: GLIA. (pp. S25 - S26). WILEY-BLACKWELL

Polke, JM; Laura, M; Pareyson, D; Taroni, F; Milani, M; Bergamin, G; Gibbons, VS; ... Reilly, MM; + view all (2011) Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations. NEUROLOGY , 77 (2) 168 - 173. 10.1212/WNL.0b013e3182242d4d.

Portaro, S; Sweeney, MG; Matthews, E; Sud, R; Musumeci, O; Rodolico, C; Vita, G; ... Hanna, M; + view all (2011) Clinical and molecular genetic studies of a cohort of Italian patients with muscle channelopathies. In: (Proceedings) 21st Meeting of the European-Neurological-Society. (pp. p. 246). SPRINGER HEIDELBERG

R

Rajakulendran, S; Paisan-Ruiz, C; Houlden, H; (2011) Thinning of the Corpus Callosum and Cerebellar Atrophy is Correlated with Phenotypic Severity in a Family with Spastic Paraplegia Type 11. J CLIN NEUROL , 7 (2) 102 - 104. 10.3988/jcn.2011.7.2.102. Gold open access

Rayan, DLR; Haworth, A; Sud, R; Burge, J; Portaro, S; Toscano, A; Hanna, MG; (2011) Large scale chloride channel gene DNA rearrangements are an important cause of recessive myotonia congenita - implications for diagnostic screening. In: NEUROMUSCULAR DISORDERS. (pp. S14 - S15). PERGAMON-ELSEVIER SCIENCE LTD

Rayan, DLR; Matthews, E; Barreto, G; Tan, SV; Dewar, L; Burge, J; Barohn, R; ... CINCH Grp, ; + view all (2011) Assessing the efficacy of Mexiletine in UK patients with non-dystrophic myotonia. In: NEUROMUSCULAR DISORDERS. (pp. S14 - S14). PERGAMON-ELSEVIER SCIENCE LTD

Rayan, DLR; Matthews, E; Rajakulendran, S; Barreto, G; Tan, SV; Dewar, L; Burge, J; ... CINCH Grp, ; + view all (2011) Genotype-phenotype correlation and longitudinal three year natural history study in the non-dystrophic myotonias in the UK. In: NEUROMUSCULAR DISORDERS. (pp. S14 - S14). PERGAMON-ELSEVIER SCIENCE LTD

Rayan, DLR; Rajakulendran, S; Barreto, G; Tan, SV; Dewar, L; Griggs, RC; Hanna, MG; (2011) Genotype-phenotype correlation and longitudinal study of Andersen-Tawil Syndrome in the UK. In: NEUROMUSCULAR DISORDERS. (pp. S14 - S14). PERGAMON-ELSEVIER SCIENCE LTD

Revesz, T; Rostagno, A; Plant, G; Lashley, T; Frangione, B; Ghiso, J; Holton, JL; (2011) Inherited Amyloidoses and Neurodegeneration: Familial British Dementia and Familial Danish Dementia. pp. 439-445. 10.1002/9781444341256.ch46.

Reynolds, EH; Healy, DG; Lees, AJ; (2011) A film of patients with movement disorders made in Queen Square, London in the Mid-1920s by Samuel Alexander Kinnier Wilson. MOVEMENT DISORDERS , 26 (14) pp. 2453-2459. 10.1002/mds.23536.

Rinaldi, S; Pitceathly, RDS; Roberts, ME; (2011) A dizzy and disorientated DJ. Pract Neurol , 11 (4) pp. 252-255. 10.1136/practneurol-2011-000065.

Rodrigues, M; de la Torre, BG; Rádis-Baptista, G; Santos, NC; Andreu, D; (2011) Efficient Cellular Delivery of β-Galactosidase Mediated by NrTPs, a New Family of Cell-Penetrating Peptides. Bioconjugate Chemistry , 22 (11) pp. 2339-2344. 10.1021/bc200421z.

Rohrer, JD; Paviour, D; Vandrovcova, J; Hodges, J; de Silva, R; Rossor, MN; (2011) Novel L284R MAPT Mutation in a Family with an Autosomal Dominant Progressive Supranuclear Palsy Syndrome. NEURODEGENER DIS , 8 (3) 149 - 152. 10.1159/000319454.

Ross, OA; Soto-Ortolaza, AI; Verbeeck, C; Rich, SS; Singleton, A; Hardy, JA; Brott, TG; ... SWISS Investigators, ; + view all (2011) Results of NOTCH3 Sequencing in Siblings with Ischemic Stroke Study Probands. In: STROKE. (pp. E269 - E269). LIPPINCOTT WILLIAMS & WILKINS

Rossor, A; Houlden, H; Reilly, MM; (2011) A clinical study of the hereditary neuropathies due to mutations in the small heat shock proteins. In: NEUROMUSCULAR DISORDERS. (pp. S18 - S19). PERGAMON-ELSEVIER SCIENCE LTD

S

Saenz, A; Ono, Y; Sorimachi, H; Goicoechea, M; Leturcq, F; Blazquez, L; Garcia-Bragado, F; ... Lopez de Munain, A; + view all (2011) DOES THE SEVERITY OF THE LGMD2A PHENOTYPE IN COMPOUND HETEROZYGOTES DEPEND ON THE COMBINATION OF MUTATIONS? MUSCLE & NERVE , 44 (5) pp. 710-714. 10.1002/mus.22194.

Sailer, A; Scholz, SW; Gibbs, JR; Johnson, JO; Wood, NW; Hernandez, D; Hardy, J; ... Houlden, H; + view all (2011) EXOME SEQUENCING AS A RAPID AND COST EFFICIENT DIAGNOSTIC METHOD IN NEUROGENETIC DISORDERS. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 552 - 552). WILEY-BLACKWELL

Schrag, A; Hobart, J; Selai, C; Quinn, N; Lees, AJ; Litvan, I; Lang, A; ... Burn, D; + view all (2011) Measuring quality of life in progressive supranuclear palsy: The PSP-QoL. pp. 52-59. 10.1017/CBO9780511975363.006.

Scoto, M; Cirak, S; Mein, R; Feng, L; Manzur, AY; Robb, S; Childs, AM; ... Muntoni, F; + view all (2011) SEPN1 related myopathies: Clinical course in a large cohort of patients. In: NEUROMUSCULAR DISORDERS. (pp. S26 - S26). PERGAMON-ELSEVIER SCIENCE LTD

Sinclair, CDJ; Morrow, JM; Fischmann, A; Hanna, MG; Reilly, MM; Yousry, TA; Golay, X; (2011) MRI shows increased tibial nerve size in CMT1A. In: NEUROMUSCULAR DISORDERS. (pp. S28 - S28). PERGAMON-ELSEVIER SCIENCE LTD

Sinclair, CDJ; Morrow, JM; Fischmann, A; Hanna, MG; Reilly, MM; Yousry, TA; Golay, X; (2011) Skeletal muscle MRI-determined fat fraction and myometric strength in inclusion body myositis and Charcot-Marie-Tooth disease Type 1A. In: NEUROMUSCULAR DISORDERS. (pp. S5 - S5). PERGAMON-ELSEVIER SCIENCE LTD

Sinclair, CDJ; Morrow, JM; Hanna, MG; Reilly, MM; Yousry, TA; Golay, X; Thornton, JS; (2011) Improved magnetization transfer MRI of skeletal muscle in myopathy and neuropathy. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S29). PERGAMON-ELSEVIER SCIENCE LTD

Siskind, C; Murphy, S; Ovens, R; Polke, J; Reilly, MM; Shy, ME; (2011) Phenotype expression in women with CMT1X. Journal of the Peripheral Nervous System , 16 (2) pp. 102-107.

Soreq, Bergman, Greenberg, Israel, Soreq, LSHBDSGIZSH; (2011) METHODS OF DIAGNOSING PARKINSON'S DISEASE.

Spillane, JE; Hanna, MG; Kullmann, DM; (2011) Synaptic mechanisms in P/Qdeficient neuromuscular junctions. In: NEUROMUSCULAR DISORDERS. (pp. S15 - S15). PERGAMON-ELSEVIER SCIENCE LTD

Statland, J; Wang, Y; Bundy, B; Trivedi, J; Herbelin, L; Pandya, S; Martens, W; ... Barohn, R; + view all (2011) A Quantitative Measure of Handgrip Myotonia in Patients with Non-Dystrophic Myotonia. In: (Proceedings) 63rd AAN Annual Meeting. (pp. A531-A531). LIPPINCOTT WILLIAMS & WILKINS

Statland, JM; Wang, Y; Richesson, R; Bundy, B; Herbelin, L; Gomes, J; Trivedi, J; ... Consortium, C, ; + view all (2011) AN INTERACTIVE VOICE RESPONSE DIARY FOR PATIENTS WITH NON-DYSTROPHIC MYOTONIA. MUSCLE NERVE , 44 (1) 30 - 35. 10.1002/mus.22007.

Stevens, J; Llewelyn, JG; Taylor, AMR; Wood, NW; (2011) Ataxia in a young patient. Pract Neurol , 11 (5) pp. 319-322. 10.1136/practneurol-2011-000097.

Sultan, SM; Allen, E; Cooper, RG; Agarwal, S; Kiely, P; Oddis, CV; Vencovsky, J; ... Isenberg, DA; + view all (2011) Interrater reliability and aspects of validity of the myositis damage index. ANN RHEUM DIS , 70 (7) 1272 - 1276. 10.1136/ard.2010.142117.

V

Vaccarino, AL; Anderson, K; Borowsky, B; Duff, K; Giuliano, J; Guttman, M; Ho, AK; ... Evs, KR; + view all (2011) An Item Response Analysis of the Motor and Behavioral Subscales of the Unified Huntington's Disease Rating Scale in Huntington Disease Gene Expansion Carriers. MOVEMENT DISORDERS , 26 (5) pp. 877-884. 10.1002/mds.23574.

W

Wall, M; Mattsson, N; Zetterberg, H; Blennow, K; (2011) [Automated cerebrospinal fluid cell count. A valuable contribution to diagnostics of brain diseases]. Lakartidningen , 108 (40) pp. 1972-1973.

Wall, M; Mattsson, N; Zetterberg, H; Blennow, K; (2011) Automatiserad cellräkning i likvor. Lakartidningen , 108 (40) pp. 1972-1973.

Wallin, A; Gothlin, M; Gustavsson, M; Zetterberg, H; Eckerstrom, C; Blennow, K; Edman, A; ... Rolstad, S; + view all (2011) Progression from Mild to Pronounced MCI Is Not Associated with Cerebrospinal Fluid Biomarker Deviations. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS , 32 (3) pp. 193-197. 10.1159/000333034.

Wedderburn, LR; Varsani, H; Charman, SC; Marie, S; Amato, AA; Banwell, B; Bove, KE; ... Holton, JL; + view all (2011) Validation and clinical testing of a standardised assessment of juvenile dermatomyositis muscle biopsy. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 13 - 14). WILEY-BLACKWELL PUBLISHING, INC

Whiffin, N; Broderick, P; Lubbe, SJ; Pittman, AM; Penegar, S; Chandler, I; Houlston, RS; (2011) MLH1-93G > A is a risk factor for MSI colorectal cancer. CARCINOGENESIS , 32 (8) pp. 1157-1161. 10.1093/carcin/bgr089.

Willis, T; Hollingsworth, KG; Sveen, ML; Morrow, JM; Sinclair, CDJ; Thornton, JS; Vandenheede, J; ... Straub, V; + view all (2011) Assessing muscle pathology by MRI in LGMD2I. In: NEUROMUSCULAR DISORDERS. (pp. S4 - S5). PERGAMON-ELSEVIER SCIENCE LTD

Willis, TA; Hollingsworth, KG; Sveen, ML; Morrow, J; Vandenheede, J; Strojkovic, T; Eagle, M; ... Straub, V; + view all (2011) Quantitative MRI in LGMD2I; a longitudinal study. In: (Proceedings) 16th International Congress of the World-Muscle-Society. (pp. p. 667). PERGAMON-ELSEVIER SCIENCE LTD

Z

Zetterberg, H; (2011) New diagnostic criteria for Alzheimer's disease. BIOMARKERS IN MEDICINE , 5 (4) pp. 407-409. 10.2217/BMM.11.46.

Zetterberg, H; (2011) Pathognomonic cerebrospinal fluid findings in Bing-Neel syndrome. JOURNAL OF NEURO-ONCOLOGY , 104 (2) p. 615. 10.1007/s11060-010-0510-4.

This list was generated on Sun Apr 15 02:06:32 2018 BST.